Open AccessUse of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs
Author(s) -
Jessica M. Fogel,
Yinfeng Zhang,
Philip J. Palumbo,
Xingzhong Guo,
William Clarke,
Autumn Breaud,
Paul Richardson,
Estelle PiwowarManning,
Erica L. Hamilton,
Tran Viet Ha,
Kostyantyn Dumchev,
Zubairi Djoerban,
Irving Hoffman,
Brett Hanscom,
William C. Miller,
Susan H. Eshleman
Publication year - 2019
Publication title -
aids and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.994
H-Index - 106
eISSN - 1573-3254
pISSN - 1090-7165
DOI - 10.1007/s10461-018-2379-8
Subject(s) - medicine , health psychology , human immunodeficiency virus (hiv) , public health , drug , antiretroviral drug , antiretroviral therapy , family medicine , viral load , psychiatry , pathology
We used antiretroviral (ARV) drug testing to evaluate the accuracy of self-reported data for HIV status and antiretroviral treatment (ART) among people who inject drugs enrolled in an HIV prevention trial. ARV drugs were detected in enrollment samples from 72/482 = 14.9% HIV-infected participants (39/52 = 75.0% who reported being on ART; 33/430 = 7.7% who reported not being on ART). Overall, 213/482 = 44.2% participants indicated that they were not aware of their HIV-positive status prior to study entry; of those, 30 had ARV drugs detected at enrollment, including 15 who also had ARV drugs detected at the screening visit. These participants were likely aware of their HIV-positive status at study entry but did not report this to study staff. This study shows that self-reported data on HIV testing history and ART may not be accurate and that ARV drug testing can help identify persons who are aware of their HIV-positive status and are on ART.